chlorhexidine has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahina, K; Li, Y; Lua, I; Pappoe, LS | 1 |
| Chiu, YH; Hsu, BG; Ke, CY; Lee, CJ; Lin, NT; Subeq, YM | 1 |
2 other study(ies) available for chlorhexidine and Cirrhosis, Liver
| Article | Year |
|---|---|
Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chlorhexidine; Down-Regulation; Epithelial Cells; Gene Deletion; Gene Expression Regulation; Liver Cirrhosis; Mice, Transgenic; Myofibroblasts; Peritoneal Cavity; Peritoneal Fibrosis; Phenotype; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Regeneration; Transforming Growth Factor beta1 | 2015 |
Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Topics: Animals; Blood Pressure; Chlorhexidine; Glucose; Heart Rate; Immunohistochemistry; Liver Cirrhosis; Male; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Protective Agents; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2011 |